Kebuzone
Appearance
![]() | |
Clinical data | |
---|---|
Routes of administration | intramuscular |
ATC code | |
Pharmacokineticdata | |
Eliminationhalf-life | 70–100 hours |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.011.560 |
Chemical and physical data | |
Formula | C19H18N2O3 |
Molar mass | 322.364g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Kebuzone(orketophenylbutazone) is anonsteroidal anti-inflammatory drug(NSAID) that is used for the treatment of inflammatory conditions such asthrombophlebitisandrheumatoid arthritis(RA).[1][2][3]
References
[edit]- ^Austria-Codex(in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
- ^"KEBUZONE".NCATS Inxight: Drugs.Retrieved2019-02-27.
- ^Aronson JK (2016)."Kebuzone".Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions(Sixteenth ed.). Amsterdam. p. 405.ISBN978-0-444-53716-4.
{{cite book}}
:CS1 maint: location missing publisher (link)